The general practitioner's approach to irritable bowel syndrome: From intention to practice

Bellini, Massimo; Tosetti, Cesare; Costa, Francesco; Biagi, S.; Stasi, Cristina; Punta, A Del; Monicelli, P; Mumolo, M. G.; Ricchiuti, Angelo; Bruzzi, Paolo; Marchi, Santino

doi:10.1016/j.dld.2005.06.011

Cited by 42 publications

(75 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, studies have shown that general practitioners rarely misdiagnose IBS and their diagnoses are in close agreement with those made by gastroenterologist [36,37] in fact, there may be a tendency to under diagnosis IBS in primary care [36,37,38,39].…”

Section: Discussionmentioning

confidence: 93%

Sex differences in dietary coping with gastrointestinal symptoms

Faresjö¹,

Johansson

Faresjö³

et al. 2010

European Journal of Gastroenterology &Amp; Hepatology

View full text Add to dashboard Cite

Aim Nutritional changes are often considered first line treatment in public health diseases which apply to many gastrointestinal disorders, since different food and beverages may modulate gastrointestinal (GI) motor and sensory functions, and provoke GI symptoms. The aim of this study was to examine dietary coping and possible changes of food and beverages intakes in relation to GI symptoms reported by identified IBS patients compared to healthy controls and if any gender differences were seen in these respects.Methods A population-based case-control design was used. Three primary health care centres in the city of Linköping in Sweden. The IBS cases were recruited from the studied primary health care centres based on diagnoses from computerized medical records. The controls were randomly selected from the general population in the same region. A questionnaire was used with specific questions about self-reported food and beverages increase or decrease of GI symptoms and self-reported changes in dietary habits.Results Female IBS-cases appear to be more willing to change dietary habits due to their GI-problems than males. Effects of these nutritional behaviour changes were reported for almost all participants that had made dietary adjustments. Fatty food, certain vegetables, dairy products and egg were significantly more reported to cause GI complaints among IBS-cases compared to their controls.Conclusions Female IBS-cases reported more changes in their dietary habits due to GI-problems than males with the disease. The majority of both females and males that changed their dietary habits due to GI problems experienced symptoms improvement.

show abstract

Section: Discussionmentioning

confidence: 93%

Sex differences in dietary coping with gastrointestinal symptoms

Faresjö¹,

Johansson

Faresjö³

et al. 2010

European Journal of Gastroenterology &Amp; Hepatology

View full text Add to dashboard Cite

show abstract

“…Frequency of mood and anxiety disorders in IBS patients evaluated in several studies and Frequency of 5%-15% for depression and 16%-19% for Anxiety have been reported (12,21) . These values of depression and anxiety are significantly more than general population (2,12,13) . While, using PSQI in IBS patients, the present study, have been dramatically calculated depression (71%), anxiety (76%), and stress (79%).…”

Section: Discussionmentioning

confidence: 97%

Assessing the Sleep Quality and Depression-Anxiety-Stress in Irritable Bowel Syndrome Patients

Baniasadi

Dehesh

Mohebbi

et al. 2017

Arq. Gastroenterol.

View full text Add to dashboard Cite

BACKGROUND Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders with chronic abdominal pain and altered bowel habit without any organic reason. Sleep disorders may be associated to IBS. OBJECTIVE We aimed to assess sleep disturbances and depression-anxiety-stress in IBS patients. METHODS In this analytical cross sectional study from November 2013 to May 2014, A total of 123 IBS patients were recruited by simple random sampling. IBS was diagnosed using ROME-III criteria. Demographic and basic data were driven from all patients then Pittsburg Sleep Quality Index questionnaire was utilized to estimate sleep quality and DASS (depression anxiety stress scale) questionnaire was filled out for depression, anxiety and stress. RESULTS The mean age of patients was 29±9, where 48 cases (39%) were male. Twelve cases (10%) had a background disease. Types of IBS in patients were included 38% diarrhea, 42% constipation and 20% mixed. From all IBS patients 87 (71%) cases had depression, 97 (79%) patients stress, 94 (76%) patients had anxiety. Seventy-six (62%) cases of IBS patients had poor sleep quality. Simultaneously employing predictors demonstrate that gender, background disease, and type of IBS did not statistically significant. On the other hand, depression (P=0.034, OR=2.35), anxiety (P=0.011, OR=3.022), and stress (P=0.029, OR=2.77) were significantly effect on sleep quality in poor sleepers. CONCLUSION Many of IBS patients is suffering from poor sleep quality. It seems that sleep disorder should be considered and treated in this patients.

show abstract

“…Because general practitioners might not be considered to be experts in the diagnostic criteria for IBS, it is possible that some IBS patients were given false-positive diagnoses. However, studies have shown that general practitioners rarely misdiagnose IBS; [46][47][48][49] in fact, there may be a tendency to underdiagnosis IBS in primary care. However, the potential for a false-negative diagnosis of IBS is not directly relevant to this study because it was not our primary purpose to determine the prevalence of IBS.…”

Section: Limitationsmentioning

confidence: 99%

Self-Reported Use of Pharmaceuticals Among Patients With Irritable Bowel Syndrome in Primary Care

Faresjö¹,

Grodzinsky²,

Johansson³

et al. 2008

JMCP

View full text Add to dashboard Cite

BACKGROUND: Irritable bowel syndrome (IBS) has an estimated 10%-12% prevalence in industrial countries. Studies from the United States have shown that IBS causes notable financial losses for employers. Due to the lack of pathophysiological markers, only a fraction of the pharmacological management of IBS has focused on etiological mechanisms. We hypothesized that there is a high consumption of nonspecific drugs among patients with IBS in their attempts to manage symptoms.OBJECTIVE: To analyze self-reported use of prescription and over-thecounter (OTC) drugs among patients with IBS in primary care compared with controls from the general population.METHODS: A population-based case-control design was used for the study. IBS cases were identified from the electronic medical records of 3 Swedish primary health care centers from January 1, 1997, through December 31, 2001. A questionnaire containing specific questions about prescription and OTC drugs was mailed in 2003 to 5,015 working-age (18-64 years) individuals (IBS cases and controls) in the Linköping IBS Population Study, a study of primary care patients with controls selected from the general population. RESULTS: After 2 reminders, the overall response rate was 63% (3,074 respondents of 4,913 deliverable surveys); 71% responded for the IBS cases (347/486) and 57% (2,509/4,427) responded for the controls. 72.3% of the IBS respondents and 51.9% of the controls were female. Acid-suppressive agents were the most commonly cited drug category for abdominal complaints reported by IBS patients (13.3%) compared with controls (1.6%) (unadjusted odds ratio [OR] = 9.20, 95% confidence interval [CI] = 5.94-14.25). Antidepressants were the most commonly cited drug category for nonabdominal complaints, reported by 13.3% of IBS patients versus 4.5% of controls (OR = 3.27, 95% CI = 2.27-4.70). An unadjusted univariate correlation analysis revealed that prescription acid-suppressive drugs, fiber and bulking laxatives, and antiflatulents and antidiarrhea drugs, as well as motility-regulating and antispasmodics drugs, were significantly more common among IBS cases compared with controls. In addition to the higher use of antidepressants, there were 3 other drug classes for nongastrointestinal complaints with a higher rate of use among IBS patients compared with controls: sedative hypnotics (OR = 2.49, CI = 1.44-4.29), analgesics (OR = 2.86, CI = 1.88-4.33), and thyroid hormones (OR = 2.43, CI = 1.39-4.26).CONCLUSIONS: There was higher use of antidepressants among patients with IBS compared with controls from the general population. Even though they are not recommended for this patient category, the use of prescription and OTC acid-suppressive drugs is also common among IBS cases in primary care.

show abstract

The general practitioner's approach to irritable bowel syndrome: From intention to practice

Cited by 42 publications

References 27 publications

Sex differences in dietary coping with gastrointestinal symptoms

Sex differences in dietary coping with gastrointestinal symptoms

Assessing the Sleep Quality and Depression-Anxiety-Stress in Irritable Bowel Syndrome Patients

Self-Reported Use of Pharmaceuticals Among Patients With Irritable Bowel Syndrome in Primary Care

Contact Info

Product

Resources

About